Nu Skin Enterprises (NUS) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY18 EPS Outlook Below Consensus, FY18 Revenue Guidance Above Consensus
Get Alerts NUS Hot Sheet
Price: $4.84 +2.98%
EPS Growth %: -5.9%
Financial Fact:
Basic (in dollars per share): 1.02
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -5.9%
Financial Fact:
Basic (in dollars per share): 1.02
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Nu Skin Enterprises (NYSE: NUS) reported Q4 EPS of $1.20, $0.01 better than the analyst estimate of $1.19. Revenue for the quarter came in at $666.2 million versus the consensus estimate of $665.44 million.
GUIDANCE:
Nu Skin Enterprises sees FY2018 EPS of $3.45-$3.65, versus the consensus of $3.65. Nu Skin Enterprises sees FY2018 revenue of $2.44-2.49 billion, versus the consensus of $2.37 billion.
For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share